We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$9.56B
AUM Growth
+$286M
Cap. Flow
-$224M
Cap. Flow %
-2.34%
Top 10 Hldgs %
15.65%
Holding
748
New
32
Increased
258
Reduced
332
Closed
44

Top Buys

Rank Stock Value
1
PINC
Premier
PINC
+$16.6M
2
PZZA icon
Papa John's
PZZA
+$16.4M
3
ARCB icon
ArcBest
ARCB
+$15.6M
4
BDX icon
Becton Dickinson
BDX
+$15.5M
5
AHCO icon
AdaptHealth
AHCO
+$15.1M

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$59M
2
PRGS icon
Progress Software
PRGS
+$49.8M
3
IMGN
Immunogen Inc
IMGN
+$23M
4
DHR icon
Danaher
DHR
+$21.6M
5
HOG icon
Harley-Davidson
HOG
+$15.5M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Industrials 18.36%
3 Healthcare 16.52%
4 Financials 12.36%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ED icon
501
Consolidated Edison
ED
$40.1B
$874K 0.01%
9,668
-66
-0.7% -$6.31K
VTV icon
502
Vanguard Morningstar Value ETF
VTV
$188B
$870K 0.01%
6,120
-107
-2% -$14.9K
XLE icon
503
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$857K 0.01%
21,110
+1,036
+5% +$42.2K
ISRG icon
504
Intuitive Surgical
ISRG
$127B
$855K 0.01%
2,501
+41
+2% +$12.4K
IWY icon
505
iShares Russell Top 200 Growth ETF
IWY
$15.9B
$838K 0.01%
5,283
-1,802
-25% -$263K
NFLX icon
506
Netflix
NFLX
$299B
$836K 0.01%
18,970
+140
+0.7% +$5.16K
BBH icon
507
VanEck Biotech ETF
BBH
$400M
$833K 0.01%
5,340
+250
+5% +$39.9K
CGNX icon
508
Cognex
CGNX
$10.9B
$829K 0.01%
14,800
ROST icon
509
Ross Stores
ROST
$80.5B
$816K 0.01%
7,275
NEM icon
510
Newmont
NEM
$98.7B
$810K 0.01%
18,982
-8,121
-30% -$369K
DTE icon
511
DTE Energy
DTE
$29.5B
$809K 0.01%
7,352
-99
-1% -$11K
GS icon
512
Goldman Sachs
GS
$300B
$808K 0.01%
2,505
-166
-6% -$54.6K
YETI icon
513
Yeti Holdings
YETI
$3.71B
$807K 0.01%
20,780
-160,919
-89% -$6.23M
SHEL icon
514
Shell
SHEL
$254B
$800K 0.01%
13,253
+427
+3% +$25.6K
REGN icon
515
Regeneron Pharmaceuticals
REGN
$78.5B
$798K 0.01%
1,110
GILD icon
516
Gilead Sciences
GILD
$162B
$790K 0.01%
10,249
+1
+0% +$80
CB icon
517
Chubb
CB
$135B
$778K 0.01%
4,040
VLO icon
518
Valero Energy
VLO
$92.9B
$765K 0.01%
6,526
-568
-8% -$66K
CL icon
519
Colgate-Palmolive
CL
$73.1B
$761K 0.01%
9,883
+200
+2% +$15.5K
PAYX icon
520
Paychex
PAYX
$41.6B
$760K 0.01%
6,795
-7
-0.1% -$766
BF.B icon
521
Brown-Forman Class B
BF.B
$13.2B
$759K 0.01%
11,372
VIG icon
522
Vanguard Dividend Appreciation ETF
VIG
$111B
$737K 0.01%
4,539
-4,946
-52% -$775K
ADM icon
523
Archer Daniels Midland
ADM
$38.2B
$735K 0.01%
9,732
-2,700
-22% -$204K
EFG icon
524
iShares MSCI EAFE Growth ETF
EFG
$16.6B
$729K 0.01%
7,636
+293
+4% +$27.9K
AEP icon
525
American Electric Power
AEP
$69.6B
$727K 0.01%
8,632
-805
-9% -$71.1K

Similar funds

Segall Bryant & Hamill's Q2 2023 Portfolio in Review

As of Q2 2023, Segall Bryant & Hamill held 748 positions worth $9.56B, up 3.1% from $9.27B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q2 2023 filing shows 32 new, 258 increased, 332 reduced and 44 closed positions. Its largest new stake was Premier: 582,008 shares worth $16.1M. The largest sale was Unilever, an estimated $59M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Segall Bryant & Hamill's largest Q2 2023 buy was Premier: 582,008 shares worth $16.1M.
  • Segall Bryant & Hamill added most to Papa John's in Q2 2023, an estimated $16.4M increase.
  • Segall Bryant & Hamill's biggest Q2 2023 reduction was Progress Software, cutting an estimated $49.8M.
  • Segall Bryant & Hamill fully exited Unilever in Q2 2023, selling an estimated $59M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $9.56B portfolio in Q2 2023.
  • Segall Bryant & Hamill opened 32 new positions and closed 44 in Q2 2023.
  • Segall Bryant & Hamill's portfolio value rose 3.1% quarter-over-quarter to $9.56B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2023, filed 14 Aug 2023.